Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
22
Number of overlapping holdings
19.8%
% of IXJ's 111 holdings also in FMED
37.9%
% of FMED's 65 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 6.6% | 4.7% | 4.7% |
|
ELI LILLY & CO | 9.4% | 2.3% | 2.3% |
|
MERCK & CO. INC. | 3.7% | 2.3% | 2.3% |
|
THERMO FISHER SCIENTIFIC INC | 2.9% | 2.2% | 2.2% |
|
DANAHER CORP | 2.2% | 3.9% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to FMED
|
ELI LILLY & CO | 7.0% |
 |
NOVO NORDISK A/S-B | 5.4% |
|
JOHNSON & JOHNSON | 4.6% |
|
ABBVIE INC | 4.2% |
 |
ASTRAZENECA PLC | 3.3% |
 |
NOVARTIS AG | 2.9% |
|
ROCHE HOLDING LTD | 2.9% |
|
ABBOTT LABORATORIES | 2.4% |
|
AMGEN INC | 2.2% |
|
PFIZER INC | 2.0% |
IXJ Underweight Relative to FMED
|
ALNYLAM PHARMACEUTICALS INC | -4.4% |
|
BOSTON SCIENTIFIC CORP | -4.1% |
|
INSULET CORP | -3.2% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.0% |
 |
ARGENX SE ADR | -2.9% |
|
EXACT SCIENCES CORP | -2.6% |
|
REGENERON PHARMACEUTICALS | -2.3% |
|
PENUMBRA, INC. | -2.1% |
|
ROYALTY PHARMA PLC CLASS A | -2.1% |
|
UCB SA | -2.1% |